This morning I met with Alessandro Vespignani, one of the network science faculty members, to discuss the overarching themes of his research. I’m always totally inspired when I walk away from these conversations and it reminded me that I haven’t had a chance to post the video our wonderful multimedia team produced earlier in the ...
In the last fifty years, pharmaceutical companies have spent tens of billions of dollars trying to find new classes of antibiotic drugs. Only one has made it into clinical practice. Seem surprising to you? Yeah, me too. At the same time, antibacterial resistance has been rising, meaning the pathogens that infect us are getting better ...